Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review

Author(s): Rohit R. Bhosale*, H. V. Gangadharappa, Umme Hani*, Riyaz Ali M. Osmani, Rudra Vaghela, P. K. Kulkarni, Venkata Sairam Koganti.

Journal Name: Current Drug Targets

Volume 18 , Issue 11 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Prostate cancer (PC) is a prostate gland cells carcinoma, the foremost reason of cancer deaths in men in developed countries, representing most common malignancy in adult males. The key obstacle to achieve practicable therapeutic effect of active drugs and capable hopeful agents including proteins and peptides, and nucleic acid for prostate cancer is the scarcity of targeted drug delivery to cells of prostate cancer. As a result, need for novel systems, strategies or therapeutic approaches to enhance the assortment of active agents meant for prostate cancer becomes an important criterion. Currently cancer research focuses on improving treatment of prostate cancer using various novel drug delivery systems of chemotherapeutic agents. These novel drug delivery systems comprise nanoparticles and liposomes. Also, strategies or therapeutic approaches intended for the prostate cancer include radiation therapy for localized prostate cancer, hormonal therapy for suppressing tumor growth, and gene-and-immunologic therapy. These systems and approaches can deliver the drugs to their selected or targeted cancer cells for the drug release in cancer atmosphere of prostate thereby enhancing the effectiveness of tumor penetration.

Objective: The objective was to collect and report the recent research findings to manage the PC. Present review encloses existing diverse novel drug delivery systems and approaches intended for the management of PC.

Conclusion: The reported miscellaneous novel drug delivery systems along with the diverse therapies are seem to be precise, secure and relatively effective; and in consequence could lead to a new track for obliteration of prostate cancer.

Keywords: Prostate cancer, delivery systems, brachytherapy, orchiectomy, gene therapy, drug targets.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 11
Year: 2017
Page: [1233 - 1249]
Pages: 17
DOI: 10.2174/1389450117666160613103705
Price: $58

Article Metrics

PDF: 21
HTML: 3